The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose escalation of LAVA-051, a novel bispecific gamma-delta T-cell engager (Gammabody), in relapsed/refractory hematological malignancies.
 
Annemiek Broijl
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Celgene; Janssen; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene
 
Niels W.C.J. van de Donk
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Roche; SERVIER; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Cellectis; Janssen; Novartis
 
Francesc Bosch
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Janssen-Cilag; Kite, a Gilead company; Lilly; Novartis; Roche/Genentech
Speakers' Bureau - Abbvie; AstraZeneca; Janssen; Roche
Research Funding - AstraZeneca; Janssen
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - BMS; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Sanofi
 
Alessandra Tucci
Consulting or Advisory Role - Janssen; Takeda
Travel, Accommodations, Expenses - sandoz
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Juno/Celgene/Bristol-Myers Squibb; Lilly; MEI Pharma; MSD; Roche; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen; Juno Therapeutics; Lilly; MEI Pharma; MSD; Roche; Sunesis Pharmaceuticals
Research Funding - Abbvie; AstraZeneca; Gilead Sciences; Janssen Oncology; Novartis; Sunesis Pharmaceuticals
 
Anton EP Adang
Employment - lava therapeutics
Leadership - lava therapeutics
Stock and Other Ownership Interests - lava therapeutics
Honoraria - lava therapeutics
 
Paul WHI Parren
Employment - lava therapeutics
Leadership - lava therapeutics; Sparring Bioconsult
Stock and Other Ownership Interests - lava therapeutics
Consulting or Advisory Role - Roche
Patents, Royalties, Other Intellectual Property - Genmab; lava therapeutics
 
Ilse Tuinhof
Employment - lava therapeutics
Stock and Other Ownership Interests - lava therapeutics
 
Sanjana Umarale
Employment - lava therapeutics
Stock and Other Ownership Interests - lava therapeutics; TG Therapeutics
 
Benjamin Winograd
Employment - lava therapeutics
Leadership - lava therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb; lava therapeutics
 
Hans J. van der Vliet
Employment - lava therapeutics
Leadership - lava therapeutics
Stock and Other Ownership Interests - lava therapeutics
Honoraria - lava therapeutics
Research Funding - Glycostem (Inst); lava therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - lava therapeutics
 
Arnon P. Kater
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen Oncology; lava therapeutics
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen Oncology; Roche/Genentech
Travel, Accommodations, Expenses - Acerta Pharma/AstraZeneca; Roche/Genentech; Roche/Genentech